Sino Biopharmaceutical Limited

Sino Biopharmaceutical Limited

0.67
USD
+0.00
(-0.05%)
12.55BMarket Cap
Apr 01Next Earn

Total Valuation

USD

As of December 31, 2021, Sino Biopharmaceutical Ltd. carries a market capitalization of 12.55B, placing it among publicly traded companies globally. Its enterprise value stands at 13.15B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap12.55B
Enterprise Value13.15B

Important Dates

Sino Biopharmaceutical Ltd.'s next confirmed earnings release is scheduled for April 1, 2027.

Earnings Date4/1/2027

Share Statistics

As of December 31, 2021, Sino Biopharmaceutical Ltd. has 18.84B shares outstanding.

Shares Outstanding18.84B

Valuation Ratios

These figures are as of December 31, 2021.

PB Ratio2.63
P/TBV Ratio2.79

Financial Position

As of December 31, 2021, Sino Biopharmaceutical Ltd. maintains a current ratio of 1.53, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities.

Current Ratio1.53
Quick Ratio1.03
Debt / Equity32.12

Financial Efficiency

These figures cover the twelve months ended December 31, 2021.

Employee Count24,475.75

Taxes

USD

Over the twelve months ended December 31, 2021, Sino Biopharmaceutical Ltd. recorded 193.89M in income tax expense.

Income Tax193.89M

Stock Price Statistics

USD

As of the close on November 11, 2026, Sino Biopharmaceutical Ltd.'s stock has declined approximately 23.16% over the past 52 weeks. The 50-day moving average sits at 0.85, while the 200-day moving average is 0.58.

52-Week Price Change-23.16%
50-Day Moving Average0.85
200-Day Moving Average0.58

Balance Sheet

USD

As of December 31, 2021, Sino Biopharmaceutical Ltd. holds 2.49B in cash and equivalents against 1.91B in total debt, resulting in a net debt position of 183.29M. Total book value stands at 4.77B, with working capital of 1.28B providing operational flexibility.

Cash & Cash Equivalents2.49B
Total Debt1.91B
Net Debt183.29M
Equity (Book Value)4.77B
Book Value Per Share0.25
Working Capital1.28B

Stock Splits

Sino Biopharmaceutical Ltd.'s most recent stock split took place on July 20, 2020 with a 2:3 split ratio.

Last Split Date7/20/2020
Split Ratio2:3